These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 391378)

  • 1. Immunofluorescence assay for antinuclear factor: a nonspecific test in hospitalized medical patients.
    Borak J; Vasey F; Lauter S; Dorval G; Osterland CK
    Can Med Assoc J; 1979 Nov; 121(10):1372-4. PubMed ID: 391378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical significance of antinuclear antibodies in connective tissue disease.
    Pahor A; Krajnc I; Gorenjak M; Holc I
    Wien Klin Wochenschr; 1998 May; 110(9):338-41. PubMed ID: 9629626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of antinuclear antibody connective tissue disease screen.
    López-Hoyos M; Rodríguez-Valverde V; Martinez-Taboada V
    Ann N Y Acad Sci; 2007 Aug; 1109():322-9. PubMed ID: 17785321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding antinuclear antibodies.
    Pertusi RM; Rubin BR
    J Am Osteopath Assoc; 1991 Jun; 91(6):563-4, 567-9. PubMed ID: 1874653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
    Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
    Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serological diagnosis of systemic connective tissue inflammation; a new immunofluorescence method for demonstrating antinuclear antibodies].
    Scagliusi P; Laghezza D; Ferrari G; Fasiello V; De Lucia M
    Minerva Med; 1981 Jan; 72(2):81-90. PubMed ID: 7007926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic significance of the antiperinuclear factor for rheumatoid arthritis.
    Janssens X; Veys EM; Verbruggen G; Declercq L
    J Rheumatol; 1988 Sep; 15(9):1346-50. PubMed ID: 3058971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of substrates for the detection of antinuclear antibodies in normals and in patients with connective tissue and other diseases.
    Lipscomb MF; Cope LD; Stephens GL; Deng JS; Gilliam JN
    Diagn Immunol; 1984; 2(3):181-7. PubMed ID: 6388982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological evaluation of in vivo epidermal nuclear fluorescence.
    Sousa JX; Miyamoto D; Zimbres JM; Costa DV; Aoki V
    Clin Exp Dermatol; 2009 Apr; 34(3):314-8. PubMed ID: 19040522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of ANA measured by ELISA compared with ANA measured by immunofluorescence.
    Maguire GA; Ginawi A; Lee J; Lim AY; Wood G; Houghton S; Kumararatne DS; Gaston HJ
    Rheumatology (Oxford); 2009 Aug; 48(8):1013-4. PubMed ID: 19491301
    [No Abstract]   [Full Text] [Related]  

  • 11. [Contribution of immunoenzymatic technics to the assay of anti-native DNA antibodies in the biological diagnosis of lupus erythematosus disseminatus].
    Laplanche S; Diemert MC; Musset L; Abuaf N; Galli J
    Ann Biol Clin (Paris); 1990; 48(3):177-81. PubMed ID: 2191610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea.
    Falanga V; Medsger TA; Reichlin M
    Arch Dermatol; 1987 Mar; 123(3):350-3. PubMed ID: 3545090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of anti-F-actin antibodies in a French multicenter study.
    Chretien-Leprince P; Ballot E; Andre C; Olsson NO; Fabien N; Escande A; Oksman F; Dubuquoi S; Jego S; Goetz J; Chevailler A; Sanmarco M; Humbel RL; Johanet C
    Ann N Y Acad Sci; 2005 Jun; 1050():266-73. PubMed ID: 16014542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basics in standardization and practical applications of immunofluorescent microscopy: standardization of antinuclear antibody tests.
    Beutner EH; Kumar V; Greenlee P
    Lab Res Methods Biol Med; 1983; 8():49-70. PubMed ID: 6358746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory screening of connective tissue diseases by a new automated ENA screening assay (EliA Symphony) in clinically defined patients.
    González C; García-Berrocal B; Pérez M; Navajo JA; Herraez O; González-Buitrago JM
    Clin Chim Acta; 2005 Sep; 359(1-2):109-14. PubMed ID: 15894301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rheumatoid arthritis with antinuclear factor. A prospective study of 50 cases (author's transl)].
    Bardin T; Dryll A; Debeyre N; Peltier AP; Ryckewaert A
    Nouv Presse Med; 1982 Feb; 11(7):501-4. PubMed ID: 6977762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cold-reacting antinuclear factor in sera from patients with primary glomerular diseases.
    Nomoto H; Watanabe S; Tomino Y; Nomoto Y; Sakai H
    Tokai J Exp Clin Med; 1985 Apr; 10(1):27-30. PubMed ID: 3913057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct immunofluorescent findings in scleroderma syndromes.
    Connolly SM; Winkelmann RK
    Acta Derm Venereol; 1981; 61(1):29-36. PubMed ID: 6164211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods.
    Homburger HA; Cahen YD; Griffiths J; Jacob GL
    Arch Pathol Lab Med; 1998 Nov; 122(11):993-9. PubMed ID: 9822128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antinuclear antibodies in rheumatology].
    Zuber M
    Z Rheumatol; 1994; 53(6):327-34. PubMed ID: 7871904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.